ca management ms 2006

Upload: bella-eakoi

Post on 02-Jun-2018

233 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 CA Management Ms 2006

    1/53

    Overview of ACLS

    May 2006

  • 8/10/2019 CA Management Ms 2006

    2/53

    900,000 people in the U.S. experience anMI annually

    ~225,000 die

    ~125,000 die in the field

    Most deaths are arrhythmic in etiology

    Acute Myocardial Infarction

    Data from: Ryan TJ et al. J Am Coll Cardiol . 1996;28:1333.

  • 8/10/2019 CA Management Ms 2006

    3/53

    Mechanisms of CA

    80-90% of non-traumatic cardiac arrests inadults are due to VF or PVTThe key action is early defibrillationMost arrests in children are respiratoryThe key action is ventilation

  • 8/10/2019 CA Management Ms 2006

    4/53

    Success of Defibrillation is

    Time-Dependent

    0

    1020

    30

    40

    50

    60

    70

    80

    90

    1 2 3 4 5 6 7 8 9

    SUCCESS

    Minutes to

    Defibrillation

    Success is reduced 7-10% per minute

  • 8/10/2019 CA Management Ms 2006

    5/53

    AED

    The AED assesses therhythm and advisesshocks for VT/VF

    After shocks resumeCPR and reassessrhythm after 5 cycles(two) minutesIf pulse returns, assessand assist breathing

  • 8/10/2019 CA Management Ms 2006

    6/53

    Pulseless VT/VFWitnessed: Consider precordial thump(optional, may be harmful)Unwitnessed: CPR for 2 minutes prior toshockShock 1 time. Level of energy withmonophasic shock: 360 J. Biphasic:

    120-200J.Resume CPR immediately after shock.Check rhythm after 2 minutes

  • 8/10/2019 CA Management Ms 2006

    7/53

    Pulseless VT/VF Persists

    After Shock Start DrugsThe key drug in CA mgmt is epinephrineFor every type of CA, epinephrine is

    given every 3-5 minutes until a pulse isrestoredVasopressin ( 40 u) may be giveninstead of the first or second dose ofepinephrineSimultaneously, intubate, oxygenateventilate

  • 8/10/2019 CA Management Ms 2006

    8/53

    CPR Pointers

    The compresssion rate is 100 per minute.Be sure compressions are full (1 - 2) andfast , but be sure that chest recoil iscomplete between compressions.Hand position is mid-sternal at nipple line

  • 8/10/2019 CA Management Ms 2006

    9/53

    CPR Pointers

    Minimize all CPR interruptionsOnce the patient is intubated do notinterrupt chest compressions forventilationFollowing intubation: Ventilation rate is 8-10 per minute. Do not hyperventilate

  • 8/10/2019 CA Management Ms 2006

    10/53

    Pulseless VT/VF

    Proceed with a drug/shock sequence. Do

    CPR for 5 cycles (2 minutes) after a drug isadministered, then shockStill in VF: amiodirone 300 mg IV. May givean additional 150 mg if VF persistsMinimize interruptions in CPR for pulsechecks

  • 8/10/2019 CA Management Ms 2006

    11/53

    Anti-Arrhythmics for PVT/VF After amiodirone: Lidocaine 1-1.5 mg/kg IV, may repeat in 3-5min (max 3 mg/kg)

    Magnesium sulfate : 1-2 gm IV for suspectedhypomagnesemia or torsades

    Procaineamide: 30 mg/min or 100 mg q5min (max 17mg/kg)Consider bicarbonate: 1mg/kg for pre-existingacidosis, drug OD, prolonged code

  • 8/10/2019 CA Management Ms 2006

    12/53

    Endotracheal Drug Adm

    VALEN: Vasopressin, atropine, lidocaine,epinephrine, naloxone

    IV administration is preferable: indicatedonly when iv access cannot be obtainedDose is 2-5X the iv dose. Dilute in sterilewater

  • 8/10/2019 CA Management Ms 2006

    13/53

    Central vs Peripheral Line

    Peripheral iv is preferred because of lessinterruption of CPR

    Peripherally administered drugs should befollowed by fluid bolus and arm elevationto facilitate delivery to central circulation

  • 8/10/2019 CA Management Ms 2006

    14/53

    80 yo comes into ER with weakness.On exam he is pale and diaphoretic, butalert and oriented and complaining ofweakness. PMH: CABG, diabetesInitial EKG:

  • 8/10/2019 CA Management Ms 2006

    15/53

  • 8/10/2019 CA Management Ms 2006

    16/53

    Acute anterior MIInitial evaluation

  • 8/10/2019 CA Management Ms 2006

    17/53

    Evaluate ABCIf adequate start O2, monitor (EKG andpulse ox), IV (OMI)iv site-antecubital

    Asa, heparin, pain control cardiologyconsult

  • 8/10/2019 CA Management Ms 2006

    18/53

    His rhythm changes

  • 8/10/2019 CA Management Ms 2006

    19/53

  • 8/10/2019 CA Management Ms 2006

    20/53

    What do you want to know?

  • 8/10/2019 CA Management Ms 2006

    21/53

    Stable or unstable-presence of serioussigns and symptoms?

    In this case starts out with BP114/70, iestable

  • 8/10/2019 CA Management Ms 2006

    22/53

    Treat with amiodarone 150mg iv over 10minutes and then infusion of 1mg/min

    Patient remains in VT-develops MSchanges and pulse weakensStable or unstable?Treatment

  • 8/10/2019 CA Management Ms 2006

    23/53

    VT with pulse, unstable-cardiovertThis means a synchronized shock-youpress the synch button on the defibConsider sedationStart with 100jPatient changes as machine is charging-now pulseless and apneic

  • 8/10/2019 CA Management Ms 2006

    24/53

  • 8/10/2019 CA Management Ms 2006

    25/53

    Shock 360j (or 200 biphasic) if the syncbutton is still pressed it wont work -turn off

    Do CPR for 2 minutes before checkingrhythmVentilate with BVM and 100% O2, intubateStart iv, give epi or vasopressin

  • 8/10/2019 CA Management Ms 2006

    26/53

    Intubation

    Secures the airway Allows administration of 100% oxygen and

    correction of respiratory acidosis Allows administration of some medications(VALEN-3X iv dose)

    What if you cant intubate??

  • 8/10/2019 CA Management Ms 2006

    27/53

    Laryngeal Mask Airway

  • 8/10/2019 CA Management Ms 2006

    28/53

    LMA

    The LMA is insertedby slipping the mask

    along the palate intothe hypopharynx withsubsequent inflationof the mask rim

  • 8/10/2019 CA Management Ms 2006

    29/53

    Epi-1 mg q3-5 min or vasopressin 40 unitsShock-still VF

    Amiodarone 300mg-shock, then 150 mgthen infusion (max 2.2 grams per 24hours)Lidocaine 1-1.5 mg/kg. Repeat x1 max3mg/kg.

  • 8/10/2019 CA Management Ms 2006

    30/53

    How do you check that the ETT is properlyplaced?

    How do you know CPR is adequate

  • 8/10/2019 CA Management Ms 2006

    31/53

    ETT placement

    Listen over both lateral lung fields and thestomach

    Use end tidal CO2 (but no CO2 if CPR isnot adequate)

  • 8/10/2019 CA Management Ms 2006

    32/53

    Adequate CPR

    Palpable carotid or femoral pulsePulse oximeter or A-lineCO2 production

  • 8/10/2019 CA Management Ms 2006

    33/53

    Vasopressin in CA

    Half life is 10-20 minutes, so considerwaiting at least 10 minutes to give

    epinephrineComparing survival in out of hospitalarrest, no advantage of vasopressin over

    epinephrine (in one study, it looked betterfor asystole)

  • 8/10/2019 CA Management Ms 2006

    34/53

    What if they come back with a pulse butinadequate BP?

  • 8/10/2019 CA Management Ms 2006

    35/53

    Low BP

    Fluid bolusDopamine-5 micrograms/kg/min titrate (put200 mcg in 250cc and start at 30drops/min)

  • 8/10/2019 CA Management Ms 2006

    36/53

    When to Stop ?

    CV unresponsivenessYou get more info about situation andcode status

  • 8/10/2019 CA Management Ms 2006

    37/53

    Asystole/PEA

    Confirm asystole in more than one lead (uselead select to move between limb leads)

    Transcutaneous pacing is ineffective for asystoleand is no longer recommendedEpinephrine: 1mg IV q3-5 min (or vasopressin*)

    Atropine: 1mg IV q 3-5 min (up to 3 doses)

  • 8/10/2019 CA Management Ms 2006

    38/53

    Consider Causes: 6Hs

    HypovolemiaHypoxiaHyper, hypokalemiaHydrogen ions (acidosis)HypothermiaHypoglycemia

  • 8/10/2019 CA Management Ms 2006

    39/53

    5Ts

    ToxinsTamponade, cardiacTension pneumothoraxThrombosis (pulmonary, coronary)Trauma

  • 8/10/2019 CA Management Ms 2006

    40/53

    PEA

    Thinking of and correcting one of thereversible causes of PEA early (eg chest

    tube placement for pneumothorax) can belifesaving

  • 8/10/2019 CA Management Ms 2006

    41/53

    Improving Survival After Cardiac

    Arrest After restoration of spontaneouscirculation, poor neurologic outcome is

    one of major causes of death2 studies have now demonstratedimproved neurologic outcome post arrest

    with the use of mild hypothermia

  • 8/10/2019 CA Management Ms 2006

    42/53

    Mild Hypothermia after VF

    Arrest136 patients comatose after VF arrest (thearrest was witnessed) were randomized to

    mild hypothermia, target 32-34 Cmeasured with a bladder probe. Patientswere sedated with fentanyl and midazolam

    and paralyzed with pancuronium andtemperature was maintained for 32 hours

  • 8/10/2019 CA Management Ms 2006

    43/53

    SURVIVAL AFTER CA

  • 8/10/2019 CA Management Ms 2006

    44/53

  • 8/10/2019 CA Management Ms 2006

    45/53

    ACLS: Managementof Tachycardias andBradycardias

  • 8/10/2019 CA Management Ms 2006

    46/53

    Bradycardia and Tachycardia

    AlgorithmsThe main important point is the distinction betweenstable vs unstable with serious signs and sxincluding:

    HypotensionShockPulmonary edema

    Loss of consciousness, confusion agitationMI , angina

  • 8/10/2019 CA Management Ms 2006

    47/53

    Tachycardia with a Pulse

    Main distinction is wide vs narrow complextachycardia. Also consider LV function.

    Assume wide complex tachycardia is VTand treat with amiodarone, lidocaine orprocaineamide if stable or synchronized

    cardioversion if unstableSynchronized cardioversion: sedate first,start with 100j

  • 8/10/2019 CA Management Ms 2006

    48/53

    Wide Complex Tachycardia

    Always assume it is VTThe drugs of choice for stable VT or widecomplex tachycardia of unknown origin areamiodarone and procaineamide

    Adenosine and verapamil are

    contraindicated for the treatment of widecomplex tachycardia

  • 8/10/2019 CA Management Ms 2006

    49/53

    Narrow Complex TachycardiaIdentify the rhythm (carotid massage,adenosine), consider cause, duration,LV function

    Tachycardia may be secondary to fever,dehydration, hypoxemia-treat theunderlying cause rather than the rhythm

    No cardioversion for: sinus tachycardia,MAT, junctional tachycardia Avoid using > one drug

  • 8/10/2019 CA Management Ms 2006

    50/53

    Atrial Flutter-Fibrillation >48h

    Agents that control rate rather thanconvert the rhythm are preferred, unless

    the patient is adequately anticoagulatedNormal LV function: diltiazem or betablockers (I)

    Abnormal LV function(EF

  • 8/10/2019 CA Management Ms 2006

    51/53

    Atrial Fibrillation

  • 8/10/2019 CA Management Ms 2006

    52/53

  • 8/10/2019 CA Management Ms 2006

    53/53

    Avoid Panic on the First Day of

    InternshipLearn the basics of ACLS including drugdoses